Adam Glick, PhD

  • Professor of Molecular Toxicology and Carcinogenesis
  • Associate Chair, Molecular Cellular and Integrative Biosciences Graduate Program
Adam Glick, PhD
306C Life Sciences Bldg
University Park, PA 16802
Work Phone: 814-865-7170

Graduate Programs


Ras is one of the most frequently mutated oncogenes in human cancer. My laboratory focuses on basic mechanisms of Ras-driven cancer in epithelial cells using both in vitro primary cell culture and in vivo transgenic and knockout mouse models. Our current focus is on the role of IRE1α (ERN1) in the cellular response to oncogenic Ras and its role in both skin and lung cancer.

Selected Publications

Dr. Glick's publications are listed in his lab website.


Please visit:

Research Interests

Immunology and Infectious Disease Research Faculty

Molecular mechanisms and signaling pathways that regulate progression of squamous tumors from a benign to malignant phenotype.

Molecular Toxicology & Carcinogenesis Research Faculty

Analysis of the tumor suppressor and oncogenic roles of Transforming Growth Factor Beta in multistage skin carcinogenesis using novel transgenic and knockout mouse models.